NCT04904510View on ClinicalTrials.gov

Evaluation of the INDICAID™ COVID-19 Rapid Antigen Test

CompletedOBSERVATIONAL
Enrollment

297

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

March 9, 2021

Study Completion Date

March 9, 2021

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

INDICAID™ COVID-19 Rapid Antigen Test

The diagnostic assay will be compared to a EUA SARS-CoV-2 assay

Trial Locations (1)

94612

CityHealth Urgent Care Oakland, Oakland

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT04904510 - Evaluation of the INDICAID™ COVID-19 Rapid Antigen Test | Biotech Hunter | Biotech Hunter